phosphatidylcholines has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 1,897 | 0 | 411 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mar, MH; Yen, CL; Zeisel, SH | 1 |
1 other study(ies) available for phosphatidylcholines and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
Article | Year |
---|---|
Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Cell Membrane; Ceramides; Choline; Cysteine Proteinase Inhibitors; Diglycerides; Enzyme Activation; PC12 Cells; Phosphatidylcholines; Rats; Sphingomyelins | 1999 |